| Financial Year |
March 31 2023 |
| Monetary Funds |
969,057,114.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
56,605,241.22 |
| Accounts Receivable |
734,069,977.17 |
| Advances to Suppliers |
16,791,176.32 |
| Other Receivables |
21,804,415.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
448,500,085.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,264,535.42 |
| Total Current Assets |
2,505,136,073.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,339,878,852.51 |
| Under-construction Projects |
22,050,723.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
255,449,178.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
106,038,595.90 |
| Other Non-Current Assets |
28,380,143.80 |
| Sub-Total of Non-Current Assets |
1,771,246,985.65 |
| Total Assets |
4,276,383,058.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
684,081,824.00 |
| Accounts Payable |
451,762,781.47 |
| Accounts Received In Advance |
269,413.32 |
| Employee Compensation Payable |
43,510,388.80 |
| Taxes Payable |
37,016,418.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
264,393,670.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,181,872.20 |
| Other Current Liabilities |
22,256,321.09 |
| Sub-Total of Current Liabilities |
1,827,208,889.10 |
| Long-term Loans |
73,444,491.78 |
| Bonds Payable |
582,067,053.39 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
34,384,237.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
922,060,456.57 |
| Total Liabilities |
2,749,269,345.67 |
| Paid-In Capital(Or Share Stock) |
136,585,243.00 |
| Capital Surplus |
487,971,115.86 |
| Surplus Reserve |
166,041,024.98 |
| LESS:Treasury Stock |
50,914,458.69 |
| Undistributed Profits |
708,522,519.49 |
| Minority Stockholder's Interest |
53,392,337.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,473,721,375.31 |
| Owner's Equity（Stockholder's Equity） |
1,527,113,713.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,276,383,058.74 |
